ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 719,00
-0,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Akoya BioSciences Inc (AKYA)

  7. Akoya BioSciences Inc (AKYA) Actualités

AKYA Akoya BioSciences Inc

4,04
0,05 (1,25%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Akoya BioSciences Inc AKYA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 1,25% 4,04 06:00:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,02 3,92 4,2288 4,04 3,99
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202414:00GLOBEAkoya Biosciences and Shanghai KR Pharmtech Announce Chinese..
22/4/202422:05GLOBEAkoya to Report First Quarter 2024 Financial Results on May..
05/4/202414:00GLOBEAkoya Biosciences Showcases Spatial Biology 2.0 Solutions at..
04/3/202423:18EDGAR2Form 8-K - Current report
04/3/202422:05GLOBEAkoya Reports Record Revenue in the Fourth Quarter of 2023..
04/3/202412:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
02/3/202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202403:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202403:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05GLOBEAkoya to Report Fourth Quarter and Full Year 2023 Financial..
18/1/202414:00GLOBEAkoya Biosciences’ Technology Enables Queensland Spatial..
10/1/202422:02EDGAR2Form 8-K - Current report
10/1/202414:00GLOBEAkoya Biosciences Announces that Garry Nolan, Ph.D., James..
08/1/202421:57DJNAkoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher..
08/1/202412:02EDGAR2Form 8-K - Current report
07/1/202414:00GLOBEAkoya Biosciences Deploys the MaxFuse Algorithm Co-Developed..
03/1/202414:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202301:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202314:05GLOBEAkoya to Participate at 42nd Annual J.P. Morgan Healthcare..
19/12/202322:23EDGAR2Form 144 - Report of proposed sale of securities
14/12/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202300:33EDGAR2Form 144 - Report of proposed sale of securities
27/11/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:37EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:06EDGAR2Form 8-K - Current report
08/11/202322:00GLOBEAkoya Reports Record Revenue in the Third Quarter of 2023..
02/11/202313:00GLOBEAkoya to Participate at Three Upcoming Investor Conferences
31/10/202314:00GLOBEAkoya Biosciences to Showcase New Spatial Biology 2.0..
17/10/202316:22GLOBEAkoya Biosciences Announces Peer-Reviewed Publication Using..
11/10/202322:05GLOBEAkoya to Report Third Quarter 2023 Financial Results on..
19/9/202314:00GLOBEAkoya Biosciences Sets a New Standard for Scaling Spatial..
06/9/202322:01EDGAR2Form 8-K - Current report
07/8/202322:10EDGAR2Form 8-K - Current report
07/8/202322:05GLOBEAkoya Reports Record Revenue in the Second Quarter of 2023..
07/8/202314:05GLOBEAkoya Biosciences Announces Milestone of 1,000 Peer-Reviewed..
26/7/202322:05GLOBEAkoya to Participate at Three Upcoming Investor Conferences
13/7/202323:10EDGAR2Form 144 - Report of proposed sale of securities
13/7/202300:28EDGAR2Form 144 - Report of proposed sale of securities
12/7/202314:05GLOBEAkoya to Report Second Quarter 2023 Financial Results on..
05/7/202322:05EDGAR2Form 8-K - Current report
28/6/202323:18EDGAR2Form 8-K - Current report
12/6/202322:05GLOBEAkoya to Participate at Two Upcoming Investor Conferences
08/6/202306:55GLOBEAkoya Biosciences Announces Pricing of Public Offering of..
08/6/202302:08DJNAkoya Biosciences Shares Fall on Executive Exits, Stock..
07/6/202322:08GLOBEAkoya Biosciences Announces Public Offering of Common Stock
08/5/202322:05GLOBEAkoya Reports Record Revenue in the First Quarter of 2023..

Dernières Valeurs Consultées

NASDAQ
AKYA
Akoya BioSciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés